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Background: Methamphetamine use is commonly accepted as an etiology of cardiomyopathy but there is very little data to characterize its 
presentation.
hypothesis: Methamphetamine associated cardiomyopathy has a distinct presentation when compared to other etiologies of 
cardiomyopathy in California’s San Joaquin Valley.
methods: We identified 1163 patients who had an echo performed between 9/2011 and 3/2013 with a LVEF < 50%. A review was 
conducted via EMR. Using diagnostic codes, etiologies by admission H&P, cardiology notes, or angiography patients were grouped by 
etiology into methamphetamine associated, ischemic or non drug associated cardiomyopathy. Demographic, lab, echo, and ECG data was 
obtained and analyzed.
results: Of the 1120 subjects identified during the study, 121 (19%) had a history of methamphetamine use. Meth users were more 
like to be younger, male, white, and have a LVEF < 30% then subjects without a history of use. Meth users were also less likely to have 
CAD, a finding likely driven by a younger average age of methamphetamine users and the large proportion of subjects with ischemic 
cardiomyopathy. Multivariate analysis showed LVEF < 30% (OR 4.26 95% CI 2.31-7.84, P = <0.002), Caucasian race (OR 2.03 95% CI 
1.2-3.43, P = 0.008) and lack of CAD (OR 0.35 95% CI 0.19-0.62, P = <0.002) were independent predictors of meth use in patients with 
cardiomyopathy.
conclusion:  Methamphetamine use is commonly associated with/etiology of cardiomyopathy in the San Joaquin Valley and has a unique 
presentation.
 
